Susquehanna International Group, LLP Ardelyx, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 945,284 shares of ARDX stock, worth $5.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
945,284
Previous 1,103,324
14.32%
Holding current value
$5.29 Million
Previous $5.42 Million
31.6%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ARDX
# of Institutions
228Shares Held
169MCall Options Held
490KPut Options Held
2.35M-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$84.3 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$64.2 Million0.06% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$63 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...